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Background: Prone breast positioning reduces skin reaction and heart and lung dose, but may also reduce
radiation dose to axillary lymph nodes (ALNs).
Methods: Women with early stage breast cancer treated with whole breast irradiation (WBI) in the prone position
were identified. Patients treated in the supine position were matched for treating physician, laterality, and
fractionation. Ipsilateral breast, tumor bed, and Level I, II, and III ALNs were contoured according to the RTOG breast
atlas. Clips marking surgically removed sentinel lymph nodes (SLN)s were contoured. Treatment plans developed for
each patient were retrospectively analyzed. V90% and V95% was calculated for each axillary level. When present,
dose to axillary surgical clips was calculated.
Results: Treatment plans for 46 women (23 prone and 23 supine) were reviewed. The mean V90% and V95% of ALN
Level I was significantly lower for patients treated in the prone position (21% and 14%, respectively) than in the
supine position (50% and 37%, respectively) (p< 0.0001 and p< 0.0001, respectively). Generally, Level II & III ALNs
received little dose in either position. Sentinel node biopsy clips were all contained within axillary Level I. The mean
V95% of SLN clips was 47% for patients treated in the supine position and 0% for patients treated in the prone
position (p< 0.0001). Mean V90% to SLN clips was 96% for women treated in the supine position but only 13% for
women treated in the prone position.
Conclusions: Standard tangential breast irradiation in the prone position results in substantially reduced dose to
the Level I axilla as compared with treatment in the supine position. For women in whom axillary coverage is
indicated such as those with positive sentinel lymph node biopsy who do not undergo completion axillary
dissection, treatment in the prone position may be inappropriate.
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The eight-year results of the ACOSOG Z0011 study
evaluating locoregional recurrence after sentinel lymph
node dissection (SLND) with or without axillary lymph
node dissection (ALND) in patients with positive sentinel
lymph nodes suggest that completion ALND may be un-
necessary for selected early stage breast cancer patients
[1,2]. Patients treated on ACOSOG Z0011 received* Correspondence: karalynne.kerr@gmail.com
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reproduction in any medium, provided the orwhole breast irradiation (WBI) with tangents in the su-
pine position. Whole breast irradiation provides moder-
ate radiation dose to the Level I and II axillary lymph
nodes (ALN)s and to the region of the sentinel node [3-
13]. If one considers that modest radiation doses to the
axilla have clinical impact, the potentially practice-
altering implications of ACOSOG Z0011 may reflect the
importance of adequate dosing of these ALNs for senti-
nel node positive patients who have not had axillary
dissection.
Recently, prone breast positioning for WBI has become
more popular in efforts to decrease radiation dose to thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Axial and coronal images of Level I contoured (violet) for a patient treated in the (a) prone and (b) supine position.
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women with pendulous breasts [9,14-17] while maintain-
ing acceptable long-term outcomes [18]. Treatment
planning studies have demonstrated the dosimetric bene-
fits of prone breast irradiation for all women, regardless
of breast size [19]. Prone positioning increases the ana-
tomic distance of the breast from the heart and lungs,
eliminates the bolus effect created by the inframammary
fold, and improves dose homogeneity as compared to
WBI in the prone position. Recent work has shown
decreased coverage of the ALNs in the prone position
when treatment plans were created for each patient inTable 1 Anatomic boundaries of the ipsilateral breast and axi
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Thoracic inletboth the prone and supine position [9]. The current
work explores dosing to axillary lymph nodes in patients
thought to be ideal candidates for prone positioning.
Methods
Forty-six women with early stage breast cancer treated
from 2009–2011 in the Departments of Radiation Oncol-
ogy at our institution with standard tangential WBI in
the prone or supine were identified. The 23 patients trea-
ted in the prone position were identified as ideal candi-
dates for treatment in the prone position prior to or at
the time of simulation for a variety of reasons includingllary lymph node Levels I-III as defined by the Radiation
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limit heart dose (n= 3). Those treated prone for large
breast size had a breast volume of 1000 mL or greater,
those treated prone to limit lung dose would have had
2.5 cm or greater of cross-sectional lung included within
a standard tangent, and those treated prone to limit
heart dose had an anteriorly located left anterior des-
cending (LAD) artery. Twenty-three patients treated in
the supine position consecutively during the same time
period (2009 – 2011) were chosen for comparison and
matched for treating physician, laterality, and fraction-
ation (conventional vs. Canadian fractionation [20]). All
patients underwent Computed Tomography (CT) -
based simulation using a Philips Brilliance Big Bore 16-
slice CT scanner (Philips Healthcare, Andover, MA).
Patients treated prone were simulated using the Bionix
Prone Breast System (Bionix Radiation Therapy, Toledo,
OH) and patients treated supine were simulated using
the Accufix Quest Breast Board (Q-Fix Systems, Wyck-
off, NJ). Three dimensional (3D) treatment planning for
all patients was performed using the Pinnacle3 (version
8.0m, Philips Medical Systems, Cleveland, OH) treat-
ment planning system. Conventional and prone breast
tangential fields were designed to encompass the whole
breast while minimizing dose to lung and heart withoutTable 2 Summary of patient characteristics
Supine (n =
Mean Age (y) ± SD* 65 ± 12
Side: Left/Right 13/10
Mean breast volume (cm3) ± SD 841 ± 369
T Stage Tis 7
T1 12
T2 4
N Stage N0 21
N1 2 2
Dissection Status: No nodal biopsy 5
Sentinel node biopsy 18
Completion axillary dissection 0
Radiation Dose 46 Gy in 23 fractions 8
42.5 Gy in 16 fractions 9
50-50.4 Gy in 25-28 fractions 6
Mean Axillary Volume Level I (cm3) ± SD 106 ± 38
Level II (cm3) ± SD 21 ± 6
Level III (cm3) ± SD 9 ± 3
* SD = standard deviation; † CI = Confidence interval.special attention to ALN coverage as confirmed by the
treating physician. No patients were treated with “high
tangents.”
Planning CT scans were retrospectively contoured to
identify ipsilateral breast tissue, tumor bed, and Level I,
II, and III ALNs according to the anatomic boundaries
set by the Radiation Therapy Oncology Group (RTOG)
contouring atlas [21], as shown in Figure 1. Table 1
delineates the boundaries of the levels in all 6 directions.
When present, clips marking sentinel lymph nodes
(SLN) removed during sentinel node biopsy were also
contoured. Ipsilateral breast and ALN Level I-III
volumes were compared between the two groups using
the t-test.
Treatment plans for each patient were retrospectively
analyzed to evaluate dose to the tumor bed, breast, and
individual nodal levels. The mean dose to the ipsilateral
breast as well as the volume of breast tissue and tumor
bed receiving 95% (V95%) of the prescribed dose were
calculated. The mean dose and the volume receiving 50%
(V50%), 90% (V90%), and 95%, of the prescribed dose
were then calculated for each axillary level. Dose to axil-
lary surgical clips was similarly calculated, when applic-
able. Mean dose, V90%, V95% of axillary Level I were
compared between those treated in the prone position23) Prone (n = 23) Comparison (two-tailed unpaired t-test)
57 ± 9
13/10











98 ± 35 p = 0.46 (CI = -30 to 14)
24 ± 7
10 ± 5 p = 0.13 (CI = -0.87 to 6.9)
p = 0.42 (CI = -3.5 to 1.5)
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tailed unpaired t-test for difference of means. For Level I,
the relative dose-volume histograms (DVH) were gener-
ated for all patients and the mean DVHs were compared
among the prone and supine groups.
Results
Table 2 provides patient characteristics for the prone
and supine cohorts. In general, patients treated in the
prone position were younger. The mean ipsilateral
breast volumes and axillary Level I, II, and III nodal
volumes (and standard deviations) are also shown in
Table 2. As expected, breast volumes tended to be
larger in the prone position than in the supine pos-
ition, but this difference did not reach statistical sig-
nificance. There was no difference in volumes
contained within the axillary nodal levels between
the two groups.
Doses (and standard deviations) delivered to the ipsi-
lateral breast, tumor bed, and all axillary levels areTable 3 Summary of calculated volume and dose to (a) ipsilat
III and to (c)sentinel lymph node (SLN) clips
a) Dose to ipsilateral breast and tumor bed
Supine (n = 23)
Ipsilateral breast mean dose (%) ± SD* 96 ± 3.8
V95% ipsilateral breast 77 ± 6.5
V95% tumor bed 99 ± 1.7
b) Dose to axillary volumes
Mean dose (%) ± SD Level I 66 ± 20
Level II 6 ±15
Level III 3 ± 2
Mean V95% ± SD Level I 37 ± 18
Level II 0
Level III 0
Mean V90% ± SD Level I 50 ± 20
Level II 1 ± 5
Level III 0
Mean V50% ± SD Level I 67 ± 19
Level II 5 ± 17
Level III 0
c) Dose to sentinel lymph node (SLN†) clips
Supine (n = 9)
SNB clips in treatment field 9
V95% SLN clips ± SD 47 ± 43
SLN clips receiving > 90% dose 8
Mean dose to SLN clips (%) ± SD 95 ± 5
*SD = standard deviation; †SLN = sentinel lymph node; ††CI = confidence interval.provided in Table 3a. Mean breast dose and V95% of ip-
silateral breast and tumor bed did not differ significantly
between those treated in the prone position and those
treated in the supine position. Only axillary Level I
received appreciable dose in both groups of patients.
Generally, Level II & III ALNs did not receive a signifi-
cant portion of prescribed dose in either position.
Within each group, there was substantial variation in
the dose coverage of axillary Level I. Among women
treated in the prone position, V95% was less than 10% in
14 women and was 0% in 6 women. Figure 2 compares
the mean Level I DVH for the prone and supine groups.
The mean dose to Level I was 36% of prescription for
patients treated in the prone position, significantly less
than the 66% of prescription for patients treated in the
supine position (p < 0.0001; 95% confidence interval =
15% to 45%). Mean V95% was lower in women treated in
the prone position as compared to women treated in the
supine position (14% vs. 37%; p < 0.0001; 95% confidence
interval = 12% to 34%).eral breast and tumor bed, to (b) axillary levels I, II, and
Prone (n = 23) Comparison (two-tailed unpaired t-test)
95 ± 1.8 p = 0.26 (CI†† = -0.77 to2.8)
74 ± 5.3 p = 0.09 (CI = -0.52 to 6.5)
98 ± 4.6 p = 0.33 (CI = -1.1 to 3.1)
36 ± 30 p< 0.0001 (CI =15 to 45)
3 ± 3
< 1 ± 0.4
14 ± 19 p < 0.0001 (CI = 12 to 34)
0
0




< 1 ± 2
0
Prone (n = 7)
2
0 ± 0 p<0.0001 (95% CI =29 to 65)
1
43 ± 34
Figure 2 Comparison of mean DVH data for patients treated in the prone and supine position.
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supine) had axillary surgical clips placed at the time of
SLN biopsy; all of the clips were located within axillary
Level I. Only two of the seven patients treated in the
prone position had clips within the tangential treatment
field. However, all SLN clips in patients treated in the su-
pine position were within the treatment field. As shown
in Table 3c, mean V95% of SLN clips was 0% for the
seven patients treated in the prone position. Mean V95%
of SLN clips was 47% among patients treated in the su-
pine position. The difference in mean V95% between the
two groups was statistically significant (p < 0.0001; 95%
confidence interval = 29% to 65%). At least 90% of pre-
scribed dose was delivered to the clips in eight of nine
patients treated supine (mean V90% = 96%), but in only
one of seven patients treated prone (mean V90%= 13%).
Discussion
The recently published eight-year results of the Ameri-
can College of Surgeons Oncology Group (ACOSOG)
Z0011 study showed no difference in axillary failure rates
or overall survival in women with cT1-2 cN0 breast can-
cer with one or two positive sentinel nodes randomized
to undergo no further axillary surgery versus completion
axillary dissection [1,2]. The locoregional control was ex-
cellent (1.8% failure) despite suspected residual disease
in approximately 40% of these women. Per protocol,
women in this study received adjuvant radiation therapy
with standard tangential irradiation. Although there has
been debate surrounding the contribution of radiation
therapy to axillary control in these women, this was
likely due to sterilization of micrometastatic disease by
tangential radiation therapy. These findings have strongimplications for the importance of adjuvant radiation
therapy to provide dose to the lower axilla in women
with positive sentinel lymph nodes who will not undergo
completion axillary dissection. In fact, regional nodal ir-
radiation has also been associated with improved survival
[22], and improvements in locoregional control have
translated into improvements in overall survival with
extended follow-up [23].
Prone breast irradiation provides clear benefits in re-
ducing skin toxicity for large breasted women and in re-
ducing heart and ipsilateral lung dose for patients with
unfavorable thoracic anatomy [9,14-18]. The present in-
vestigation suggests that axillary nodal coverage should
also be considered when making the decision to treat
women in the prone versus supine position. The data
presented in this study suggest that irradiation in the
prone position does not allow for the same coverage of
axillary tissue as does irradiation in the supine position.
Although the classic anatomic boundaries of the axilla
are well defined, the clinically relevant borders are not.
There is substantial variation in definition of boundaries
of the axilla used in radiotherapy treatment as outlined
in Table 4. For the purpose of standardizing the borders
of the axilla, the RTOG published a contouring atlas
[21]. Perhaps contrary to classic teaching, recent litera-
ture (including the present study) suggests that standard
tangential whole breast irradiation delivers the pre-
scribed dose to only a portion of Level I of the axilla,
particularly as defined by the RTOG. In the present
study, only 37% of the Level I volume received 95% of
the dose with standard tangential irradiation. It is not
clear whether this level of coverage delivers sufficient
dose for therapeutic treatment of axillary lymph nodes.
Table 4 Review of the literature reporting boundaries of and dose to axillary Level I volumes and/or clips in patients







Borders of axillary Level I Dose to Level I
Krasin et al. [3] 25 2D sim/3D
analysis
ALND* 16 Not listed Mean dose = 32
Gy (63.5%)
Aristei et al. [4] 35 2D sim/3D
analysis
ALND 35 Caudal border: Inferior clip D90% = 6.75 Gy
Cranial border: Axillary
vein and 2nd clip
Medial border: Lateral border
of pectoralis minor
Lateral border: Axillary vein
Posterior border: Latissimus dorsi
Takeda et al. [5] 44 2D sim/3D analysis ALND 44 Caudal border: Clip in latissimus
dorsi at inferior level of dissection
Median V80% = 30.5%
Cranial border: Clip in the latissimus
dorsi at level of axillary vein
Posterior border: Clip in adjacent
to subscapularis vein
Orecchia et al. [6] 15 3D CRT† SNB†† 15 Caudal border: SNB clip Mean dose = 48.7%
Cranial border Manubrium ± 22%
35 3D CRT SNB N/A Caudal border: Between 4th
and 5th ribs
V95% = 51% ± 16%
Reznik et al. [7] Cranial border: Axillary vein Mean dose = 66% ± 13%
Medial border: Pectoralis minor
Reed et al. [8] 50 3D CRT 32 SNB 50 Caudal border: Latissiumus dorsi
and clavipectoral-lattisimus fascia
Mean V95% = 55%
Median V95% = 53%
18 ALND Cranial border: Most inferior axial
image of axillary artery/vein
Medial border: Pectoralis minor
Lateral border: Medial aspect of
pectoralis seratus
Anterior border: Pectoralis minor




20 3D CRT Not reported N/A Caudal border: Origin of pectoralis
minor 3rd – 5th ribs
V95% < 60%
Cranial border: Pectoralis minor
insertion of the coracoid process
Prone: Mean
dose = 11.2 Gy
Medial border: Pectoralis minor Supine: Mean
dose = 21 Gy
Lateral border: Latissimus dorsi
Posterior border: Latissimus dorsi
Schlembach
et al. [10]
105 3D CRT 65 SNB 105 Surgical clips 85% of clips in the field




45 2D ALND 45 Surgical clips 38% of clips in field
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Table 4 Review of the literature reporting boundaries of and dose to axillary Level I volumes and/or clips in patients
undergoing tangential radiation therapy as part of breast conservation therapy (Continued)
Chung et al. [12] 36 2D or 3D CRT SNB 36 Surgical clips 94% of clips in field
Present study 46 3D CRT SNB 7 prone RTOG Atlas [20] Prone: V95% = 14%
9 supine Mean dose = 36% ± 31%
Mean dose to clips = 43%
Supine: V95% = 37% (supine)
Mean dose = 66% ± 20%
Mean dose to clips = 95%
*ALND = Axillary lymph node dissection; †3DCRT = Three dimensional conformal radiation therapy; ††SNB = Sentinel node biopsy.
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with standard tangents have suggested that such cover-
age does not provide adequate doses to control residual
microscopic disease in the axilla [3,7]. The present study
suggests that the area of the axilla receiving fully dose
(90-95% of the prescribed dose) may contain the micro-
scopic disease. In fact, the clinically important target tis-
sue in the axilla has not yet been clearly defined. The
98% locoregional control seen in ACOSOG Z0011 with
SNLD alone suggests that standard tangential fields en-
compass the clinically relevant nodal tissue.
The location of clips placed during SNLD may repre-
sent the area at highest risk of harboring metastatic dis-
ease after SNLD alone. Certainly, we know that the
sentinel node is the most likely to contain breast cancer
metastases. The neighboring nodes may represent the
next echelon for metastatic spread. Despite suboptimal
coverage of the entire nodal volume, standard tangents
provide substantial dose to the clips placed to mark the
location of the sentinel lymph node as shown in this
study as well as others [8,10,12]. However, for women
treated in the prone position, the area marked by SNLD
clips receives minimal radiation dose. This raises con-
cern that treatment in the prone position may provide
suboptimal coverage of the most clinically important ax-
illary nodal areas.
The study by Stegman et al., which showed a 5-year re-
gional control rate of 98.4% in 245 patients treated with
WBI in the prone position demonstrates that prone ir-
radiation provides adequate adjuvant treatment for the
pathologically negative axilla and for the positive axilla
that has undergone a full Level 1, 2 axillary lymph node
dissection [18]. This excellent axillary control rate is
expected in a population of women comprised of 15% of
patients with DCIS and 65% of patients with pN0 dis-
ease. Importantly, all women with positive lymph nodes
in the Stegman study underwent Level 1, 2 axillary
lymph node dissection. The undissected node-positive
population in the ACOSOG Z0011 is at substantially
higher risk for regional failure and likely receives sub-
stantial benefit from standard tangential irradiation.Results similar to ours were published by Alonso-
Basanta et al., who reported on twenty patients simulated
in both the prone and supine position [9]. The mean
dose to the axilla was 11.2 Gy when patients were simu-
lated in the prone position and 21 Gy when the same
patients were simulated in the supine position. The
authors stated that alternative positioning was warranted
in eight of the twenty patients for anatomic reasons (i.e.,
breast size, lung dose), while in the present study, all
twenty-three patients treated prone were determined to
be ideal candidates for prone positioning by the treating
radiation oncologist. Thus, the current investigation
includes patients in whom such a dosimetric evaluation
is most critical. Moreover, the present study includes the
novel finding that tangential irradiation in the supine
position provides significantly better coverage of sentinel
lymph node tissue than tangential irradiation in the
prone position.
The limitations of the present study include a small
sample size and the inherent sample bias associated with
retrospective trial design. Additionally, only a small
number of patients had SNLD clips placed, limiting the
analysis of radiation dose delivery to axillary clips. While
care was taken to choose an appropriate supine match
for each prone patient, differences may inherently exist
between the two groups. Although there was no signifi-
cant difference in mean breast size or mean axillary vol-
ume between the two groups, other differences may exist
that could bias the results. For example, patients in the
prone group are slightly younger than patients in the su-
pine group.
Conclusion
Standard tangential breast irradiation in the prone pos-
ition results in substantially reduced dose to the Level I
axilla as compared with treatment in the supine position.
For women in whom axillary coverage is indicated such
as those with positive sentinel lymph node biopsy who
do not undergo completion axillary dissection, treatment
in the prone position may be inappropriate. For women
with DCIS or those with a negative sentinel node biopsy,
Leonard et al. Radiation Oncology 2012, 7:72 Page 8 of 8
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coverage of target breast tissue.
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